use neutralize initial data lab microbiologist utmb suggest n501y variant original virus genetic alterations spell bad news monoclonal antibody treatments virus december 1 preprint study found mutations drove changes segment virus lies close regions recognized monoclonals pharmaceutical companies eli lilly regeneron pathogen pressing question farzan new variant affect existing covid-19 vaccines development new ones not appear b.1.1.7 resist authorized vaccines developed pfizer moderna respectively companies tested fact mutations accumulating spike protein mean vaccines extended period time somewhat effective problem force vaccine developers adapt products ensure target new versions virus lot people think going like flu new vaccine year weaver says